$16.780
+0.601 (+3.58%)收盘时
技术面情绪
综合共识
技术分析共识
移动平均线共识
Scribe Therapeutics Inc. Common Stock（SCTX）的 MACD 指标为 -1.68，显示 SCTX 为 Sell。
Scribe Therapeutics Inc. Common Stock（SCTX）20 日简单移动平均线为 18.20，而 Scribe Therapeutics Inc. Common Stock（SCTX）股价为 $—，使其为 Sell。
Scribe Therapeutics Inc. Common Stock（SCTX）60 日简单移动平均线为 23.83，而 Scribe Therapeutics Inc. Common Stock（SCTX）股价为 $—，使其为 Sell。
SCTX 技术分析
AI 技术分析 SCTXAs of 2026-11-02, the technical board for Scribe Therapeutics Inc. Common Stock (SCTX) reads sell: 2 indicators are flashing buy, 7 are indicating sell, and 4 are neutral. Price at $16.78 sits below the 20-day, 60-day and 200-day moving averages and above the 5-day and 10-day.
Momentum readings: RSI stands at 42.603, MACD stands at -1.683 (Sell), Stochastic %K stands at 25.446, Stochastic %D stands at 20.82 and CCI stands at -52.114.
SCTX trades below the 60-day SMA (23.83) and below the 200-day SMA (23.36). Immediate resistance sits at Classic R1 18.90, then R2 21.41. Support sits at Classic S1 14.08, then S2 11.77.
Scribe Therapeutics Inc. Common Stock（SCTX）支撑与阻力位
Scribe Therapeutics Inc. Common Stock（SCTX）技术指标
2026-11-03
| 名称 | 数值 |
|---|---|
| RSI_14 | 42.603 |
| STOCHk_14_3_3 | 25.446 |
| STOCHd_14_3_3 | 20.820 |
| CCI_20 | -52.114 |
| AO_5_34 | -3.652 |
| MOM_10 | -2.520 |
| MACD_12_26_9 | -1.683 |
Scribe Therapeutics Inc. Common Stock（SCTX）的 Relative Strength Index (RSI_14) 为 42.603，形成中性信号。
Scribe Therapeutics Inc. Common Stock（SCTX）的 Stochastic %K 为 25.446，形成中性信号。
Scribe Therapeutics Inc. Common Stock（SCTX）的 Stochastic %D 为 20.820，形成中性信号。
Scribe Therapeutics Inc. Common Stock（SCTX）的 CCI_20 为 -52.114，形成中性信号。
Scribe Therapeutics Inc. Common Stock（SCTX）的 Awesome Oscillator (AO) 为 -3.652，形成 Sell 信号。
Scribe Therapeutics Inc. Common Stock（SCTX）的 Momentum (MOM) 为 -2.520，形成 Sell 信号。
Scribe Therapeutics Inc. Common Stock（SCTX）的 Moving Average Convergence Divergence (MACD) 为 -1.683，形成 Sell 信号。
Scribe Therapeutics Inc. Common Stock（SCTX）移动平均线
2026-11-03
| 周期 | 简单 | 信号 |
|---|---|---|
| MA_5 | 16.276 | Buy |
| MA_10 | 16.385 | Buy |
| MA_20 | 18.205 | Sell |
| MA_60 | 23.833 | Sell |
| MA_200 | 23.356 | Sell |
| MA_250 | 23.356 | Sell |
Scribe Therapeutics Inc. Common Stock（SCTX）的 5 日 简单移动平均线为 16.276，而 Scribe Therapeutics Inc. Common Stock（SCTX）股价为 $，使其为 Buy。
Scribe Therapeutics Inc. Common Stock（SCTX）的 10 日 简单移动平均线为 16.385，而 Scribe Therapeutics Inc. Common Stock（SCTX）股价为 $，使其为 Buy。
Scribe Therapeutics Inc. Common Stock（SCTX）的 20 日 简单移动平均线为 18.205，而 Scribe Therapeutics Inc. Common Stock（SCTX）股价为 $，使其为 Sell。
Scribe Therapeutics Inc. Common Stock（SCTX）的 60 日 简单移动平均线为 23.833，而 Scribe Therapeutics Inc. Common Stock（SCTX）股价为 $，使其为 Sell。
Scribe Therapeutics Inc. Common Stock（SCTX）的 200 日 简单移动平均线为 23.356，而 Scribe Therapeutics Inc. Common Stock（SCTX）股价为 $，使其为 Sell。
Scribe Therapeutics Inc. Common Stock（SCTX）的 250 日 简单移动平均线为 23.356，而 Scribe Therapeutics Inc. Common Stock（SCTX）股价为 $，使其为 Sell。
相关文章
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。